Solwers updates its EBITA calculation method and supplements its reporting with new alternative performance measures

Solwers Plc is updating its EBITA calculation method to better align with market practice and is making a corresponding adjustment to its mid-term EBITA margin target. The company said its overall profitability target remains unchanged, while introducing new APMs including adjusted EBITA, adjusted EBITA margin, and ROCE to improve transparency and comparability. The announcement is largely methodological and unlikely to materially affect near-term valuation.

Analysis

This is less about accounting cosmetics and more about management trying to re-anchor the valuation conversation before the next capital allocation debate. By harmonizing EBITA and introducing ROCE, they are signaling a shift from narrative-led growth framing toward capital efficiency, which typically matters more when organic expansion slows and the market starts asking whether roll-up economics are still compounding or merely being normalized.

The second-order effect is that any peer comparison based on legacy EBITA may now compress the apparent gap between Solwers and higher-quality Nordic consultancies, but only if the market believes the new definition is conservative. If not, investors will treat the move as guidance management: a mechanical reset that can temporarily support optics while leaving underlying unit economics unchanged. That usually creates a short window where sell-side models get revised, volatility rises, and the stock can underperform if the new margin target implies less operating leverage than previously assumed.

The key risk is credibility, not the APM itself. If adjusted EBITA begins to diverge materially from reported EBITA over the next 1-2 reporting cycles, the market will discount the new framework and focus on cash conversion, especially working capital and acquisition-related integration costs. Conversely, if ROCE improves while margins merely stabilize, the re-rating potential is real because it supports a higher-quality multiple for a services roll-up over the next 6-12 months.

Contrarian view: the announcement may be mildly bullish because it reduces the chance of future disappointment by setting a cleaner baseline now. The market often penalizes companies for opaque metric changes only when they coincide with deteriorating fundamentals; here, the transparency upgrade could remove a governance discount faster than it changes earnings estimates.

Key Decisions for Investors

• If liquid, consider a tactical long in any Nordic consulting/service peer with clean ROCE disclosure versus a short in Solwers on a 1-3 month horizon; the cleaner-disclosure name should attract multiple expansion if this triggers a sector-wide quality rerating.
• Avoid chasing the stock immediately after model resets; wait for the next quarterly print and compare adjusted EBITA to cash flow. If conversion weakens, use any post-release strength to initiate a short or underweight.
• For investors already long, trim into strength and re-enter only if ROCE improves over 2 consecutive quarters; that is the clearest catalyst for a durable rerating over 6-12 months.
• If options are available and liquidity supports it, buy a modest downside hedge into the next earnings date; metric changes often increase event risk and the stock can gap lower if the market reads the target adjustment as a hidden downgrade.